FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 100mg tablets (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 100mg tablets (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Desogestrel 75microgram tablets 168 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Desogestrel 75microgram tablets 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Desogestrel 75microgram tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Desogestrel 75microgram tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Flecainide 50mg tablets 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Aristo Pharma Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 50mg capsules (Sovereign Medical Ltd) 84 capsule 6 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 50mg capsules (Sovereign Medical Ltd) 84 capsule 6 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Sovereign Medical Ltd) 56 capsule 4 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Sovereign Medical Ltd) 56 capsule 4 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitisinone 5mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitisinone 5mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nitisinone 10mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nitisinone 10mg capsules (Logixx Pharma Solutions Ltd) 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Eplerenone 25mg tablets (Tillomed Laboratories Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Eplerenone 25mg tablets (Tillomed Laboratories Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Eplerenone 50mg tablets (Tillomed Laboratories Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Eplerenone 50mg tablets (Tillomed Laboratories Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 50mg tablets (Tillomed Laboratories Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Flecainide 100mg tablets (Tillomed Laboratories Ltd) 100 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 100mg tablets (Tillomed Laboratories Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Labetalol 200mg tablets (Tillomed Laboratories Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 500mg powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 1g powder for solution for injection vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) 56 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) 56 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 323 of 342 Next End

    This concept is not in any reference sets

    Back to Start